DelveInsight’s ‘Scleroderma Pipeline Insights’ report lays down a holistic coverage of the available therapies, Scleroderma pipeline therapies in different developmental phases of clinical trials, key ...

Bob Saget was a tireless activist for the Scleroderma Research Foundation, inspired by the death of his sister, Gay Bob Saget was all about the jokes. But his family life was anything but funny. In ...

SCLERODERMA is a condition that results in hard, thickened areas of skin. Although it is relatively uncommon, it can sometimes cause problems with internal organs and ...

Forty-six patients with scleroderma (3 male and 43 female) and 31 healthy controls (6 male and 25 female) were included in the study. Twenty-five patients had limited-type and 21 patients had ...

The overall benefit of blood pressure control is best achieved by a gradual reduction in pressure (10-15 mmHg per day) until the diastolic pressure reaches 85-90 mmHg. An excessive reduction in ...

Scleroderma is classified as a rare, autoimmune, collagen-vascular disease of unknown etiology that can be difficult to diagnose and treat. Its onset can be insidious or rapid; the symptoms range from ...

Screening for a sometimes fatal condition among patients with a rare autoimmune disease could soon - thanks to a computer algorithm - become even more accurate. Researchers at Michigan Medicine found ...

A drug approved to treat certain types of cancer has shown promising results in the treatment of patients with scleroderma, according to results from an open-label Phase II trial. While the drug's ...

Patients with a certain type of scleroderma may get cancer and scleroderma simultaneously, researchers have found, suggesting that in some diseases, autoimmunity and cancer may be linked. Patients ...

Specialty biotechnology company Gemelli Biotech has announced the launch of a blood test that measures anti-vinculin levels to help physicians identify the risk of gastrointestinal or vascular ...